Feng Wang

Title: The Innovative Contributions of Feng Wang

Introduction

Feng Wang is a notable inventor based in Cincinnati, OH (US), recognized for his significant contributions to the field of therapeutic interventions. With a total of 3 patents, he has made strides in developing innovative solutions that address critical health issues.

Latest Patents

Feng Wang's latest patents include groundbreaking work on Y2 selective receptor agonists for therapeutic interventions. His modified human PP peptides, specifically (i) [Lys4,Leu17,Ser30,Gln34]hPP, (ii) [Lys4,Leu17,Thr30,Gln34]hPP, and (iii) [Lys4,Leu17,oxidised Met30,Gln34]hPP, are designed to selectively target the Y2 receptor. These peptides are useful for applications such as appetite control and therapeutic angiogenesis. Additionally, he has developed melanocortin receptor ligands, which include MC-4 and/or MC-3 receptor ligands that feature a suitable linking group comprising at least one amino acid.

Career Highlights

Throughout his career, Feng Wang has worked with prominent companies, including Procter & Gamble and 7tm Pharma. His experience in these organizations has allowed him to refine his skills and contribute to significant advancements in his field.

Collaborations

Feng Wang has collaborated with notable colleagues, including Adam W Mazur and Russell James Sheldon, enhancing the impact of his work through shared expertise and innovative ideas.

Conclusion

Feng Wang's contributions to the field of therapeutic interventions through his patents and collaborations highlight his role as a leading inventor. His work continues to pave the way for advancements in health-related technologies.